CD34 and acute myeloid leukemia: Next, we identified well-characterized AML-associated oncogenic genes, such as WT1, FLT3, KIT, GATA2, IDH2, and SMC1A, and validated their gene expression in CD34+ cells derived from peripheral/bone marrow blood of AML patients by RT‒qPCR.